Quincy Siu-Chung Chu
11PUBLICATIONS
67CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Aug 05, 2025
Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.Funda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia
|May 12, 2025
Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib study.Glenwood Goss, Tudor Ciuleanu, Rodryg Ramlau
|Apr 23, 2025
Cost-Effectiveness of Adjuvant Alectinib Versus Chemotherapy for Patients with Resectable, ALK-positive Non-small Cell Lung Cancer in Canada.Nick Jovanoski, Sarah Vaselenak, Andrew Hogan
|Jan 08, 2025
Treatment of Pleural Mesothelioma: ASCO Guideline Update.Hedy L Kindler, Nofisat Ismaila, Lyudmila Bazhenova
|Jan 08, 2025
The continually evolving landscape of novel therapies in oncogene-driven advanced non-small-cell lung cancer.Barbara Melosky, Rosalyn A Juergens, Shantanu Banerji
|Dec 13, 2024
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies.Jason J Luke, Karen Gelmon, Lillian L Siu
Pageof 2
Frequent Collaborators
2 joint publications
Barbara Melosky
2 joint publications
Giuseppe Curigliano
1 joint publications
Roy S Herbst
1 joint publications
Alfredo Sanchez-Hernandez
1 joint publications
D Ross Camidge
1 joint publications
Zachary A Cooper
1 joint publications
Rakesh Kumar
1 joint publications
Charu Aggarwal
1 joint publications
Alex Martinez-Marti
1 joint publications
Hedy L Kindler
